Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Merck & Co., Inc.
  6. News
  7. Summary
    MRK   US58933Y1055

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about MERCK & CO., INC.
10/15MERCK : And Co. Gets European Medicines Agency's Positive Opinions on Pneumonia Vaccine, C..
MT
10/15MERCK : Receives Positive Opinions From European Medicines Agency on Pneumonia Vaccine, Ca..
MT
10/15Merck, Eisai Get CHMP Backing for Lenvima-Keytruda Combo in Two Cancers
DJ
10/15MERCK : and Eisai Receive Positive EU CHMP Opinions for KEYTRUDA® (pembrolizumab) Plus LEN..
BU
10/15MERCK : Receives Positive CHMP Opinion for VAXNEUVANCE™ (Pneumococcal 15-valent Conj..
BU
10/15Merck Gets CHMP Positive Opinion for Vaxneuvance Vaccine
DJ
10/15MERCK : US FDA To Review Merck & Co.'s COVID-19 Antiviral Drug For Approval In Late Novemb..
MT
10/14MERCK : FDA to Review Merck's Emergency Use Authorization Request For Molnupiravir COVID-1..
MT
10/14MERCK : Nov 30th FDA Advisory Committee meeting to Discuss Merck & Ridgeback's COVID-19 An..
MT
10/14MERCK : Acceleron Pharma Shareholder Says Merck & Co.'s Offer Significantly Undervalues Co..
MT
10/13MERCK : FDA Approves Merck's KEYTRUDA® (pembrolizumab) Plus Chemotherapy, With or Without ..
BU
10/12MERCK : EU Eyeing Supply Deal With Merck and Co. For COVID-19 Pill
MT
10/12MERCK : Morgan Stanley Adjusts Price Target on Merck & Company to $88 From $85, Maintains ..
MT
10/12Merck Completes New Viral Vector Contract Development Manufacturing Facility for Gene T..
CI
10/12MERCK : Launches Tender Offer to Buy Acceleron Pharma at $180 Per Share
MT
More most relevant news
All news about MERCK & CO., INC.
10/15MERCK : And Co. Gets European Medicines Agency's Positive Opinions on Pneumonia Vaccine, C..
MT
10/15MERCK : Receives Positive Opinions From European Medicines Agency on Pneumonia Vaccine, Ca..
MT
10/15Merck, Eisai Get CHMP Backing for Lenvima-Keytruda Combo in Two Cancers
DJ
10/15MERCK : and Eisai Receive Positive EU CHMP Opinions for KEYTRUDA® (pembrolizumab) Plus LEN..
BU
10/15MERCK : Receives Positive CHMP Opinion for VAXNEUVANCE™ (Pneumococcal 15-valent Conj..
BU
10/15Merck Gets CHMP Positive Opinion for Vaxneuvance Vaccine
DJ
10/15MERCK : US FDA To Review Merck & Co.'s COVID-19 Antiviral Drug For Approval In Late Novemb..
MT
10/14MERCK : FDA to Review Merck's Emergency Use Authorization Request For Molnupiravir COVID-1..
MT
10/14MERCK : Nov 30th FDA Advisory Committee meeting to Discuss Merck & Ridgeback's COVID-19 An..
MT
10/14MERCK : Acceleron Pharma Shareholder Says Merck & Co.'s Offer Significantly Undervalues Co..
MT
More news
News in other languages on MERCK & CO., INC.
10/15Merck And Co. Obtention d'avis positifs de l'Agence européenne des médicaments sur un v..
10/15MERCK : le CHMP a accordé des avis positifs
10/15Merck & Co erhält EU-Zulassungsemfehlung bei Krebsmittel
10/15La FDA américaine examinera le médicament antiviral COVID-19 de Merck & Co. en vue d'un..
10/14La FDA examinera la demande d'autorisation d'utilisation d'urgence de Merck pour le méd..
10/14Un actionnaire d'Acceleron Pharma affirme que l'offre de Merck & Co. sous-évalue consid..
10/12MÄRKTE USA/Etwas leichter - Anleger vor Berichtssaison in Wartestellung
10/12Selon Morgan Stanley, Pfizer et Merck devraient revoir leurs perspectives à la hausse d..
10/12MÄRKTE USA/Börsen treten auf der Stelle
10/12L'UE envisage un accord de fourniture avec Merck and Co. pour la pilule COVID-19
More news
Analyst Recommendations on MERCK & CO., INC.
10/12MERCK : Morgan Stanley Adjusts Price Target on Merck & Company to $88 From $85, Maintains ..
MT
10/08MERCK : Barclays Adjusts Merck & Co.'s Price Target to $92 from $87, Keeps Overweight Rati..
MT
10/08MERCK : Receives Price Target Boost to $92 From $86 From Berenberg Bank; Hold Rating Maint..
MT
10/05ANALYST RECOMMENDATIONS : Chipotle Mexican Grill, Coherent, Merck, Microchip Technology, V..
10/04MERCK : Atlantic Equities Adjusts Merck & Company PT to $100 From $92, Maintains Overweigh..
MT
More recommendations
Press releases
10/15MERCK : and Eisai Receive Positive EU CHMP Opinions for KEYTRUDA® (pembrolizumab) Plus LEN..
BU
10/15MERCK : Receives Positive CHMP Opinion for VAXNEUVANCE™ (Pneumococcal 15-valent Conj..
BU
10/13MERCK : FDA Approves Merck's KEYTRUDA® (pembrolizumab) Plus Chemotherapy, With or Without ..
BU
10/13Astellas and Seagen Complete Enrollment in EV-103 Trial Cohort K Combining PADCEV (enfo..
AQ
10/12MERCK : Begins Tender Offer to Acquire Acceleron Pharma Inc.
BU
More press releases
Analysis
Merck pill seen as 'huge advance,' raises hope of preventing COVID-19 deaths
Stock Pick
 MERCK AND COMPANY
Leader in oncology, modest valuation
Upcoming event on MERCK & CO., INC.
10/28/21Q3 2021 Earnings Call
Upcoming sector events
10/19/21JOHNSON & JOHNSON : Q3 2021 Earnings Release
10/26/21ELI LILLY AND COMPANY : Q3 2021 Earnings Release
11/02/21PFIZER INC. : Q3 2021 Earnings Release
11/03/21NOVO NORDISK A/S : Q3 2021 Earnings Release
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals